Publication:
BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer

dc.contributor.buuauthorErtürk, Elif
dc.contributor.buuauthorÇeçener, Gülşah
dc.contributor.buuauthorTezcan, Gülçin
dc.contributor.buuauthorEgeli, Ünal
dc.contributor.buuauthorTunca, Berrin
dc.contributor.buuauthorGökgöz, Şehsuvar
dc.contributor.buuauthorTolunay, Şahsine
dc.contributor.buuauthorTaşdelen, İsmet
dc.contributor.departmentSağlık Meslek Yükseokulu
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıbbi Patoloji Ana Bilim Dalı
dc.contributor.departmentTıbbi Biyoloji Ana Bilim Dalı
dc.contributor.departmentTıbbi Laboratuvar Teknikleri Programı
dc.contributor.departmentGenel Cerrahi Ana Bilim Dalı
dc.contributor.orcid0000-0001-7668-796X
dc.contributor.orcid0000-0002-3820-424X
dc.contributor.orcid0000-0002-5956-8755
dc.contributor.orcid0000-0001-7904-883X
dc.contributor.orcid0000-0002-1619-6680
dc.contributor.orcid0000-0003-1394-2630
dc.contributor.orcid0000-0002-9038-0515
dc.contributor.researcheridAAK-3371-2021
dc.contributor.researcheridAAP-9988-2020
dc.contributor.researcheridAAH-3843-2020
dc.contributor.researcheridAAH-1420-2021
dc.contributor.researcheridABI-6078-2020
dc.contributor.researcheridEXK-4525-2022
dc.contributor.researcheridAAI-1612-2021
dc.contributor.researcheridEBN-1186-2022
dc.contributor.scopusid50261655300
dc.contributor.scopusid6508156530
dc.contributor.scopusid25650627600
dc.contributor.scopusid55665145000
dc.contributor.scopusid6602965754
dc.contributor.scopusid6603238737
dc.contributor.scopusid6602604390
dc.contributor.scopusid9637821500
dc.date.accessioned2022-09-09T12:12:56Z
dc.date.available2022-09-09T12:12:56Z
dc.date.issued2015-02-10
dc.description.abstractTriple negative breast cancer (TNBC) is the most aggressive and poorly understood subclass of breast cancer (BC). Over the recent years, miRNA expression studies have been providing certain detailed overview that aberrant expression of miRNAs is associated with TNBC. Although TNBC tumors are strongly connected with loss of function of BRCA genes, there is no knowledge about the effect of BRCA mutation status on miRNA expressions in TNBC cases. The aims of this study were to evaluate the expression profile of miRNAs that plays role in TNBC progression and the role of BRCA mutations in their regulation. The expression level of BC associated 13 miRNAs was analyzed in 7 BRCA mutations positive, 6 BRCA mutations negative TNBC cases and 20 non-tumoral tissues using RT-PCR. According to RT2 Profiler PCR Array Data Analysis, let-7a expression was 4.67 fold reduced in TNBCs as compared to normal tissues (P = 0.031). In addition, miR-200c expression was 5.75 fold reduced in BRCA mutation positive TNBC tumors (P = 0.005). Analysis revealed a negative correlation between miR-200c and VEGFA expressions (r = -468). Thus, miR-200c may be involved in invasion and metastasis in TNBC cases with BRCA mutation. In this study we provide the knowledge on the first report of association between microRNA-200c and BRCA mutations in TNBC. Further studies and evaluations are required, but this miRNA may provide novel therapeutic molecular targets for TNBC treatment and new directions for the development of anticancer drugs.
dc.identifier.citationErtürk, E. vd. (2015). "BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer". Gene, 556(2), 163-169.
dc.identifier.endpage169
dc.identifier.issn0378-1119
dc.identifier.issn1879-0038
dc.identifier.issue2
dc.identifier.pubmed25445393
dc.identifier.scopus2-s2.0-84919872180
dc.identifier.startpage163
dc.identifier.urihttps://doi.org/10.1016/j.gene.2014.11.047
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0378111914013249
dc.identifier.urihttp://hdl.handle.net/11452/28614
dc.identifier.volume556
dc.identifier.wos000349589800012
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier
dc.relation.bapUAP(T)-2011/1
dc.relation.journalGene
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBRCA1/2 gene mutations
dc.subjectMicroRNA
dc.subjectMiR-200c
dc.subjectTriple negative breast cancer
dc.subjectEpithelial-mesenchymal transition
dc.subjectDown-regulation
dc.subjectOvarian-cancer
dc.subjectFeedback loop
dc.subjectFamily
dc.subjectZeb1
dc.subjectMicroRNA-200c
dc.subjectProgression
dc.subjectMetastasis
dc.subjectResistance
dc.subject.emtreeBRCA1 protein
dc.subject.emtreeBRCA1 protein, human
dc.subject.emtreeBRCA2 protein
dc.subject.emtreeBRCA2 protein, human
dc.subject.emtreeMicroRNA
dc.subject.emtreeMırn200 microrna, human
dc.subject.emtreeMirnlet7 microRNA, human
dc.subject.emtreeVasculotropin A
dc.subject.emtreeVEGFA protein, human
dc.subject.emtreeAdult
dc.subject.emtreeArticle
dc.subject.emtreeCancer growth
dc.subject.emtreeClinical article
dc.subject.emtreeControlled study
dc.subject.emtreeFemale
dc.subject.emtreeGene expression profiling
dc.subject.emtreeGene expression regulation
dc.subject.emtreeGene mutation
dc.subject.emtreeHuman
dc.subject.emtreeHuman tissue
dc.subject.emtreeLet 7a gene
dc.subject.emtreeOncogene
dc.subject.emtreeReverse transcription polymerase chain reaction
dc.subject.emtreeTriple negative breast cancer
dc.subject.emtreeTumor invasion
dc.subject.emtreeVEGFA gene
dc.subject.emtreeDisease course
dc.subject.emtreeGenetics
dc.subject.emtreeMiddle aged
dc.subject.emtreeMutation
dc.subject.emtreePathology
dc.subject.emtreeTriple negative breast cancer
dc.subject.meshAdult
dc.subject.meshBRCA1 protein
dc.subject.meshBRCA2 protein
dc.subject.meshDisease progression
dc.subject.meshFemale
dc.subject.meshGene expression regulation
dc.subject.meshNeoplastic
dc.subject.meshHumans
dc.subject.meshMicroRNAs
dc.subject.meshMiddle aged
dc.subject.meshMutation
dc.subject.meshTriple negative breast neoplasms
dc.subject.meshVascular endothelial growth factor A
dc.subject.scopusCirculating Microrna; Stomach Neoplasms; Breast Neoplasms
dc.subject.wosGenetics & Heredity
dc.titleBRCA mutations cause reduction in miR-200c expression in triple negative breast cancer
dc.typeArticle
dc.wos.quartileQ3
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentSağlık Meslek Yükseokulu/Tıbbi Laboratuvar Teknikleri Programı
local.contributor.departmentTıp Fakültesi/Tıbbi Biyoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Genel Cerrahi Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Tıbbi Patoloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: